Literature DB >> 21704768

Analytical aspects of microRNA in diagnostics: a review.

Mariàngels de Planell-Saguer1, María Celina Rodicio.   

Abstract

MicroRNAs (miRNA) are short (∼22 nucleotides) non-coding RNA molecules that regulate gene expression at the post-transcriptional level. Their expression is specific to cells and tissues and is temporally regulated. miRNAs are known to be involved in developmental and physiological processes, and their dysregulation leads to development of diseases. Since their profiles reflect pathological processes, miRNAs have recently been proposed as being useful in diagnostics as biomarkers of the onset, prognosis and risk of diseases, as well as in the classification of different types of cancer. The establishment of miRNA profiles that are representative of diseases and the detection of different types and levels of miRNA in samples are therefore critical milestones in diagnostics. miRNAs can be detected in blood and body fluids as well as in tissues, thus making non-invasive collection of samples possible. For a method to be useful in diagnostics, it should be simple, inexpensive and highly sensitive. Here, we will review current methods of detecting miRNAs and indicate the advantages and disadvantages of each techniques. We will then summarize some of the clinical evidence for the potential application of miRNAs as biomarkers in diagnostics. We conclude providing some general perspectives on the use of miRNAs in clinical situations, including therapeutic applications.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21704768     DOI: 10.1016/j.aca.2011.05.025

Source DB:  PubMed          Journal:  Anal Chim Acta        ISSN: 0003-2670            Impact factor:   6.558


  67 in total

Review 1.  Cell-free microRNAs as cancer biomarkers: the odyssey of miRNAs through body fluids.

Authors:  Mohammad Amin Javidi; Amir Hossein Ahmadi; Babak Bakhshinejad; Nazila Nouraee; Sadegh Babashah; Majid Sadeghizadeh
Journal:  Med Oncol       Date:  2014-11-02       Impact factor: 3.064

Review 2.  MicroRNAs in liver disease.

Authors:  Xin Wei Wang; Niels H H Heegaard; Henrik Orum
Journal:  Gastroenterology       Date:  2012-04-11       Impact factor: 22.682

Review 3.  Epigenetic biomarkers in skin cancer.

Authors:  Edward S Greenberg; Kelly K Chong; Kelly T Huynh; Ryo Tanaka; Dave S B Hoon
Journal:  Cancer Lett       Date:  2012-01-27       Impact factor: 8.679

Review 4.  Epigenetic mechanisms in stroke and epilepsy.

Authors:  Jee-Yeon Hwang; Kelly A Aromolaran; R Suzanne Zukin
Journal:  Neuropsychopharmacology       Date:  2012-08-15       Impact factor: 7.853

5.  Hemolysis-free plasma miR-214 as novel biomarker of gastric cancer and is correlated with distant metastasis.

Authors:  Ke-Cheng Zhang; Hong-Qing Xi; Jian-Xin Cui; Wei-Song Shen; Ji-Yang Li; Bo Wei; Lin Chen
Journal:  Am J Cancer Res       Date:  2015-01-15       Impact factor: 6.166

6.  Sensitive and multiplexed on-chip microRNA profiling in oil-isolated hydrogel chambers.

Authors:  Hyewon Lee; Rathi L Srinivas; Ankur Gupta; Patrick S Doyle
Journal:  Angew Chem Int Ed Engl       Date:  2015-01-07       Impact factor: 15.336

Review 7.  Pattern recognition for predictive, preventive, and personalized medicine in cancer.

Authors:  Tingting Cheng; Xianquan Zhan
Journal:  EPMA J       Date:  2017-03-09       Impact factor: 6.543

8.  Prediction and validation of potential pathogenic microRNAs involved in Phytophthora infestans infection.

Authors:  Juanjuan Cui; Yushi Luan; Weichen Wang; Junmiao Zhai
Journal:  Mol Biol Rep       Date:  2014-01-16       Impact factor: 2.316

9.  Ultraspecific analyte detection by direct kinetic fingerprinting of single molecules.

Authors:  Tanmay Chatterjee; Zi Li; Kunal Khanna; Karen Montoya; Muneesh Tewari; Nils G Walter; Alexander Johnson-Buck
Journal:  Trends Analyt Chem       Date:  2019-12-04       Impact factor: 12.296

Review 10.  MicroRNAs and Transplantation.

Authors:  Zahraa Khan; Manikkam Suthanthiran; Thangamani Muthukumar
Journal:  Clin Lab Med       Date:  2018-12-22       Impact factor: 1.935

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.